Literature DB >> 34147372

Leveraging implementation science to increase the translation of deprescribing evidence into practice.

Nagham J Ailabouni1, Emily Reeve2, Christian D Helfrich3, Sarah N Hilmer4, Bradley H Wagenaar5.   

Abstract

Implementation science may address some of the limitations that impede the translation of deprescribing recommendations into practice and policy. Application of principles and standard terminologies from implementation science could improve understanding and interpretation of deprescribing research findings. As such, in this commentary we propose three main avenues to help achieve this. These include: The application of these concepts derived from implementation science could help inform future deprescribing needs for clinicians and researchers. Ultimately, this could help ensure the quality use of medications and examination of meaningful outcomes in deprescribing studies. This could result in more consistent and widespread translation of deprescribing evidence into practice and policy across various healthcare settings.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Contextual determinants; Deprescribing; Implementation outcomes; Implementation science

Mesh:

Year:  2021        PMID: 34147372     DOI: 10.1016/j.sapharm.2021.05.018

Source DB:  PubMed          Journal:  Res Social Adm Pharm        ISSN: 1551-7411


  3 in total

Review 1.  N-of-1 trials to facilitate evidence-based deprescribing: Rationale and case study.

Authors:  Parag Goyal; Monika M Safford; Sarah N Hilmer; Michael A Steinman; Daniel D Matlock; Mathew S Maurer; Mark S Lachs; Ian M Kronish
Journal:  Br J Clin Pharmacol       Date:  2022-07-13       Impact factor: 3.716

2.  Barriers and facilitators of successful deprescribing as described by older patients living with frailty, their informal carers and clinicians: a qualitative interview study.

Authors:  George Peat; Beth Fylan; Iuri Marques; David K Raynor; Liz Breen; Janice Olaniyan; David Phillip Alldred
Journal:  BMJ Open       Date:  2022-03-28       Impact factor: 2.692

3.  Development and Validation of Comprehensive Healthcare Providers' Opinions, Preferences, and Attitudes towards Deprescribing (CHOPPED Questionnaire).

Authors:  Iva Bužančić; Maja Ortner Hadžiabdić
Journal:  Pharmacy (Basel)       Date:  2022-07-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.